Search

Start typing to see results...

  • Home
  • >
  • Stock Market
  • >
  • Lupin Ltd

Lupin Ltd

Pharmaceuticals - Indian - Bulk Drugs & Formln
NSE BSE

2,340.00

-11.60 (-0.49%)
As on: 22-Jun-2026 , 10:05 PM
Market Cap(₹Cr) 107536.52
Book Value(₹Cr) 659.0470742
BSE Code : 500257 NSE Symbol : LUPIN EPS(TTM) : 131.91 ISIN Demat : INE326A01037 P/E(TTM) : 17.83 Face Value(₹) : 2 Div & Yield % : 0.77

Today Market

Stock Performance

Today Market

Today's High

77,325.56

Todday's Low

77,008.02

Open at

77,160.67

Previous Close

76,802.90

Volumes

Avg Price

291.17

Historical Performance

News

18 Jun 26
Lupin gains after launching generic hypertension drug in the US
The product is bioequivalent to Edarbi of Azurity Pharmaceuticals and is indicated for the treatment of hypertension in adults to lower blood pressure.
17 Jun 26
Lupin launches generic hypertension drug in the US
The product is bioequivalent to Edarbi of Azurity Pharmaceuticals and is indicated for the treatment of hypertension in adults to lower blood pressure.
08 Jun 26
Lupin partners with Spain's ERN for launch of asthma, COPD inhaler Luforbec
The inhaler is indicated for the treatment of adult asthma and chronic obstructive pulmonary disease (COPD) in Spain.
08 Jun 26
Lupin launches Luforbec' inhaler in Spain
Lupin today announced its strategic collaboration with LABORATORIOS ERN S.A. (ERN), a well-established Spanish pharmaceutical company, for the launch of Luforbec' (beclometasone/formoterol) 100/6, a fixed dose combination in a pressurized metered dose inhaler, for the treatment of adult asthma and chronic obstructive pulmonary disease, in Spain.

Historical Prices

Share Price Chart

Historical Share Price

From Date:
To Date:     

Date Open Price (₹) High Price(₹) Low Price(₹) Close Price(₹) Total Volume No of Trades Net Turnover(₹) NIFTY
22-06-26 2360.00 2371.90 2335.70 2340.00 719167 37966 1689209949.50 24102.90
19-06-26 2303.20 2355.80 2303.20 2351.60 1186959 51755 2777238625.80 24013.10
18-06-26 2283.80 2337.90 2279.20 2327.10 934007 48678 2158242029.90 24168.00
17-06-26 2272.70 2284.30 2253.60 2272.00 594226 24039 1347560262.20 24085.70
16-06-26 2284.40 2286.70 2255.10 2277.80 388578 23807 882373195.20 23989.15
15-06-26 2296.90 2304.00 2261.10 2273.10 696820 37418 1586496419.30 23853.90
12-06-26 2282.00 2297.10 2269.50 2293.30 613853 26707 1402552545.10 23622.90
11-06-26 2247.20 2286.00 2246.20 2273.30 1038391 49921 2357837664.30 23161.60
10-06-26 2264.20 2280.50 2242.10 2247.20 734927 59814 1664865076.40 23214.95
09-06-26 2261.70 2271.40 2247.30 2264.20 732939 21999 1658749044.60 23242.10
123...

Fundamentals

Company Valuation

Market Cap (₹cr)

107536.52

PE Ratio

17.83

PB Ratio

3.57

Dividend Yield

0.77

ROE

17.70

ROCE

21.32

Book Value (₹)

659.0470742

Face Value (₹)

2

Share Holding Pattern

Category of Shareholder No of Shares % Share Holdings Demat Shares Share Holders
plus  Promoter & Group
plus  Foreign
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 1286394 0.28 1286394 3
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 1286394 0.28 1286394 3
plus  Indian
Bodies Corporate-Indian (Promoter & Group) 207194390 45.32 207194390 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 5730900 1.25 5730900 7
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 1000 0.00 1000 1
Others 0 0.00 0 0
Sub Total 212926290 46.57 212926290 9
Total ShareHolding for Promoter & Group 214212684 46.86 214212684 12
plus   Publice Share Holding
plus  Institution
Government(Central / State) 9711 0.00 9711 2
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 11231 0.00 9831 7
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 99243654 21.71 99243654 872
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 27993018 6.12 27993018 31
Mutual Funds / UTI 77384469 16.93 77381869 41
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 10369238 2.27 10369238 26
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 215011321 47.03 215007321 979
plus  Non Institution
Bodies Corporate 1205823 0.26 1199823 1096
Clearing Members 358392 0.08 358392 60
Directors & their Relatives 10000 0.00 10000 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 5000 0.00 5000 1
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1743993 0.38 1743593 9053
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 533740 0.12 533740 4059
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 619470 0.14 619470 4
Individuals holding nominal share capital up to Rs. 1 lakh 22474651 4.92 22047370 274993
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 125826 0.03 125826 25
Others 802190 0.18 802190 1
Sub Total 27955106 6.11 27521425 289420
Total Public Shareholding 242966427 53.14 242528746 290399
Total of Promoter & Public ShareHolding 457179111 100.00 456741430 290411
plus  Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total 457179111 100.00 456741430 290411

Financials (₹ in cr)

Consolidated Standalone
Year EndMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Net Sales22,707.9020,010.8216,641.6616,405.4815,162.96
OPM (%)17.6812.104.31-8.3611.06
OP4,015.002,422.27716.49-1,372.211,676.45
Other Income201.61130.68150.91210.09136.29
PBIDT5,479.133,930.691,871.48429.272,704.50
INTEREST294.87311.61274.30142.77140.64
PBDT5,184.263,619.081,597.18286.502,563.86
PBT4,015.002,422.27716.49-1,372.211,676.45
EO0.000.000.000.000.00
PBT after EO4,015.002,422.27716.49-1,372.211,676.45
TAXES708.74486.70268.80137.15448.52
PAT3,281.621,914.48430.08-1,528.041,216.53
EPS71.6941.879.41-33.6526.72
Raw Material19.6320.7022.1619.7220.90
Power and Fuel2.112.462.882.712.73
Employee Cost17.4617.4618.5518.2218.64
Other Manufacturing Expenses0.000.000.000.000.00
Selling and Administration Expenses16.1916.7516.5615.1814.71
Miscellaneous Expenses2.142.442.4013.982.14
Revenue (Growth %) 13.4820.251.448.19-1.38
PBIDT (Growth %)39.39110.03335.97-84.1329.38
PAT (Growth %) 71.41345.15-128.15-225.61-551.59
PBIDT (Margin %)24.1319.6411.252.6217.84
PAT (Margin %) 14.459.572.58-9.318.02

Balance Sheet (₹ in cr)

Particulars (Sources Of Funds)Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Share Capital 91.3291.1491.0090.9090.7490.60
Reserves Total 24186.9220511.8718320.8618059.2918474.7817382.52
Equity Share Warrants0.000.000.000.000.000.00
Equity Application Money0.000.080.000.000.050.08
Total Shareholders Funds24278.2420603.0918411.8618150.1918565.5717473.20
Secured Loans 0.000.000.000.0050.795.29
Unsecured Loans 250.13104.93748.51950.85434.670.54
Total Debt250.13104.93748.51950.85485.465.83
Other Liabilities508.74426.89393.84338.24357.66458.26
Total Liabilities25037.1121134.9119554.2119439.2819408.6917937.29
APPLICATION OF FUNDS :
Gross Block 8672.997605.397408.436705.146230.285666.14
Less : Accumulated Depreciation 3727.133492.223386.503014.962591.452152.26
Less:Impairment of Assets0.000.000.000.000.000.00
Net Block 4945.864113.174021.933690.183638.833513.88
Lease Adjustment0.000.000.000.000.000.00
Capital Work in Progress278.37445.83926.59947.44950.86822.00
Producing Properties0.000.000.000.000.000.00
Investments 11955.0311580.679974.339511.099562.587456.43
Current Assets, Loans & Advances
Inventories 3227.222969.313019.473177.142708.192484.61
Sundry Debtors 5664.353842.152674.422722.013190.543616.33
Cash and Bank Balance458.58138.64100.9764.56284.011305.93
Loans and Advances 1540.841528.921336.291651.711113.641101.91
Total Current Assets10890.998479.027131.157615.427296.388508.78
Less : Current Liabilities and Provisions
Current Liabilities 2715.642783.942132.401887.091693.381960.10
Provisions 523.95848.00812.04800.25539.17590.17
Total Current Liabilities & Provisions3239.593631.942944.442687.342232.552550.27
Net Current Assets7651.404847.084186.714928.085063.835958.51
Miscellaneous Expenses not written off 0.000.000.000.000.000.00
Deferred Tax Assets279.05224.38187.250.000.00162.06
Deferred Tax Liability434.34380.39372.27186.75217.32355.00
Net Deferred Tax-155.29-156.01-185.02-186.75-217.32-192.94
Other Assets361.74304.17629.67549.24409.91379.41
Total Assets25037.1121134.9119554.2119439.2819408.6917937.29
Contingent Liabilities3637.353538.704312.643472.564875.596559.75

Cash Flow (₹ in cr)

Yearly Cash FlowMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Financing Activities -53.17102.45-498.26-867.07-460.23
Investing Activities -2,507.52-371.79-1,269.17-1,599.02-1,766.32
Net Cash Flow -990.61-118.3126.5638.04218.10
Operating Activities 1,570.08151.031,793.992,504.132,444.65

Peers

Balance Sheet Financial Ratios Profit & Loss
Aarti Pharmalabs...

678.00

(-1.99%)
Accent Microcell...

448.30

(-0.82%)
Accretion Pharma...

141.65

(-1.25%)
Achyut Healthcar...

Advanced Enzyme ...

374.95

(+0.33%)
Akums Drugs & Ph...

617.25

(+2.08%)
Albert David Ltd

711.00

(-0.02%)
Alembic Pharmace...

780.75

(+2.33%)

Corporate Actions

Bonus Dividends Splits
DateCorporate ActionInformation
No Corporate Actions Announced

Board of Directors

Chairman & Chief Executive Officer
MDG
M D Gupta
Chairman (Non-Executive)
Executive
VG
Vinita Gupta
Director & Chief Executive Officer
Executive
Functional Directors
NDG
Nilesh Deshbandhu Gupta.
Managing Director
MD
RS
Ramesh Swaminathan
Director & Group CFO
Dir.
Independent Directors
JB
Jean-Luc Belingard
Independent Director
Ind.
MDM
Mark D McDade
Independent Director
Ind.
KBS
K B S Anand
Independent Director
Ind.
JK
Jeffrey Kindler
Independent Director
Ind.
AZ
Alfonso Zulueta
Independent Director
Ind.
PL
Punita Lal
Independent Director
Ind.
Other Officials
RVS
R V Satam
Company Sec. & Compli. Officer
Board

Invest with clarity

on Chola Securities Mobile & Web App.

Stay organised, informed & in control while accessing your portfolio, reports, trading tools and service requests—all in one seamless platform.

Download the app now → The new app is listed as Chola Securities- Prime Access on App store & Google Play.
Also available on Web, Click to explore
Trading App Screen
We are hiring! Check out open positions and send your CV to csecrecruit@chola.murugappa.com
View Careers
Pre-Apply for IPOs
Chola Securities App
Install
🌐
Stay on Web